Biofilm infections, their resilience to therapy and innovative treatment strategies.
about
Bacteriophages as Weapons Against Bacterial Biofilms in the Food IndustryIntrigues of biofilm: A perspective in veterinary medicine.Nanoparticle-Based Antimicrobials: Surface Functionality is CriticalGenetic control of bacterial biofilmsMechanisms of Candida biofilm drug resistanceCyclic di-GMP: the first 25 years of a universal bacterial second messengerTreatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics toolsMicrobial biofilm formation: a need to actInfiltration of Matrix-Non-producers Weakens the Salmonella Biofilm and Impairs Its Antimicrobial Tolerance and PathogenicityMechanism of activation of bacterial cellulose synthase by cyclic di-GMP.Microbial Biofilms in Urinary Tract Infections and Prostatitis: Etiology, Pathogenicity, and Combating strategiesPhage therapy against Enterococcus faecalis in dental root canalsProgrammable biofilm-based materials from engineered curli nanofibresDevelopment of an in vitro Assay, Based on the BioFilm Ring Test(®), for Rapid Profiling of Biofilm-Growing BacteriaPhosphorylation-dependent derepression by the response regulator HnoC in the Shewanella oneidensis nitric oxide signaling networkA narrative review of microbial biofilm in postoperative surgical site infections: clinical presentation and treatment.Antibiofilm properties of interfacially active lipase immobilized porous polycaprolactam prepared by LB techniqueComprehensive analysis of phospholipids and glycolipids in the opportunistic pathogen Enterococcus faecalisAminoglycoside inhibition of Staphylococcus aureus biofilm formation is nutrient dependent.Approaches to Dispersing Medical Biofilms.Impact of the functional status of saeRS on in vivo phenotypes of Staphylococcus aureus sarA mutantsIdentification of appropriate reference genes for qPCR studies in Staphylococcus pseudintermedius and preliminary assessment of icaA gene expression in biofilm-embedded bacteriaA broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms.Rasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance.Antibacterial and anti-biofilm activity of flavonoids and triterpenes isolated from the extracts of Ficus sansibarica Warb. subsp. sansibarica (Moraceae) extracts.Biofilms and persistent wound infections in United States military trauma patients: a case-control analysisComparison of the antibiotic activities of Daptomycin, Vancomycin, and the investigational Fluoroquinolone Delafloxacin against biofilms from Staphylococcus aureus clinical isolates.Antiadhesive and antibiofilm activity of hyaluronic acid against bacteria responsible for respiratory tract infections.Mutation in the C-di-AMP cyclase dacA affects fitness and resistance of methicillin resistant Staphylococcus aureus.The global anaerobic regulator Anr, is involved in cell attachment and aggregation influencing the first stages of biofilm development in Pseudomonas extremaustralis.Structural and biological evaluation of lignin addition to simple and silver-doped hydroxyapatite thin films synthesized by matrix-assisted pulsed laser evaporation.Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model.Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human PathogensPublic Health Risks of Multiple-Drug-Resistant Enterococcus spp. in Southeast AsiaA paradigm for the evaluation and management of spinal coccidioidomycosisEffect of Twice-Daily Blue Light Treatment on Matrix-Rich Biofilm Development.Cold Plasma Inactivation of Bacterial Biofilms and Reduction of Quorum Sensing Regulated Virulence Factors.Biofilm models of polymicrobial infection.Superantigens produced by catheter-associated Staphylococcus aureus elicit systemic inflammatory disease in the absence of bacteremia.Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model
P2860
Q26745094-16F711AB-A607-4E02-92E9-2832CEA84681Q26751336-931A74BE-4107-4A13-9620-0D10325EDC44Q26752437-CC6023C0-781D-47C8-84D2-A2FAD86C1EFAQ26796226-C319B5BC-ED69-4FA3-A793-FFCB44BD02D7Q26827521-A089EF61-63F5-475C-9AED-749F1A818C35Q26850396-07964982-3407-4D54-BE3E-E42699224E8BQ26997004-0ACBE514-66A1-4F7B-A1CF-56BCBE7AB5F3Q27007396-E64D85D3-5157-4C96-9A7B-E7FF674AAF90Q27325649-ACD061FC-A68A-4EBA-B3E5-EB4D3E56F5A1Q27682969-09B6D719-8E1A-4AD4-B359-52F94328719EQ28066856-EEF2DEF2-AF58-4BD8-9286-8C2041162021Q28071930-0CF52898-D54D-423D-86D9-B1231AD4B8B9Q28248161-15280E53-5862-4647-8037-C99CA48FE80BQ28829570-8EB8AE72-B6EC-43A2-B9F1-2626D95EFF62Q29346661-B77979B5-DB3A-4073-9E1C-0A8C2A83B6CAQ30240106-6EEB23F4-1666-4EE9-A85D-570DB104B80FQ33567752-9DEB79CF-6BCB-4ADA-B543-9E4C9F649800Q33579777-E12F101B-1F04-4477-AF72-AB7D15F28DDCQ33647713-75D19043-3660-4B88-B73A-B0D8E0F12835Q33845349-0736FABD-D1A7-4BD6-A1CE-04D33D2C1B93Q33854742-B91DD4BD-185E-41CA-9BFF-6992D3404951Q33988606-0C8B5DEC-3E16-49FC-BBC2-81D8459B8ACDQ34057449-1FE2697F-D586-4146-AA33-29F558D02AA9Q34360893-BEE9ACC6-9212-4D8E-9406-C6F6E21A394DQ34367309-7209D21E-71A2-4510-A4F2-87DE6A34BEA9Q34524371-79EBC005-AA77-49CB-83F9-B72319540B13Q34596619-8FD83814-B18F-48DA-B4D2-E6B3BD09E4F8Q34661017-19CC0A02-7D99-473B-8CEB-6F33EBB7CD66Q34981051-6DEBDE52-AF96-4C9B-8A3E-2482D80BDACEQ35022901-0390DA18-B26C-4E84-91A7-A23418429EFBQ35541241-EBB65626-6D9F-4042-AF5D-A66A67622B80Q35580712-BF802469-2514-4F45-9CE8-53951CC80D2BQ35658468-C0370CD4-BE09-498E-96B1-06BAA98CABA7Q35684908-F181B62C-AF45-46E0-B174-F252D3CC49CEQ35689236-BBBA35FF-3242-4984-8E8B-04B2EC18F09FQ35730019-B6EBF664-1EA1-4EAE-8A43-D3FFB3A756F5Q35782074-72CC16B4-BFD9-4E1A-BB78-5987B0D98D84Q35848074-52646BA1-2203-40A7-8624-0EB5551649B5Q35850035-7B7AAD26-3ADE-4045-8C98-E0F478FB9BF4Q35859931-3336B72E-5D24-4009-8EEB-FDAE5FA229F3
P2860
Biofilm infections, their resilience to therapy and innovative treatment strategies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biofilm infections, their resilience to therapy and innovative treatment strategies.
@en
type
label
Biofilm infections, their resilience to therapy and innovative treatment strategies.
@en
prefLabel
Biofilm infections, their resilience to therapy and innovative treatment strategies.
@en
P2860
P356
P1476
Biofilm infections, their resilience to therapy and innovative treatment strategies.
@en
P2860
P304
P356
10.1111/JOIM.12004
P407
P577
2012-10-29T00:00:00Z